Cite
MLA Citation
Cosimo Di Raimondo et al.. “Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type.” British journal of haematology, vol. 187, 2019, pp. e79–e82. http://access.bl.uk/ark:/81055/vdc_100094617029.0x00005f